How to ID Patients with Difficult-to-Control Asthma

Activity Overview

Understanding the mechanisms of disease has dramatically shifted our therapeutic strategies and methods of patient stratification when treating asthma. The advent of new clinical biomarkers, differential understanding of phenotypes and endotypes, and the introduction of biologics has come with questions of patient selection and suitability for novel treatment strategies. This activity combines the powerful impact of artistic design, infographic presentation, and scientific expertise to deliver the latest in asthma pathophysiology, disease heterogeneity, and biomarker understanding to help inform optimal treatment selection.

CE Credit Expired

Target Audience

The target audience for this activity is pulmonary and allergy/immunology providers including physicians, nurse practitioners, and physician assistants who manage patients with asthma.

Learning Objectives

Upon successful completion of this education activity, participants should be better able to:

  • Distinguish between the different types of asthma based on underlying pathophysiology and biomarkers of disease in order to make personalized treatment decisions
  • Identify patients with poorly-controlled or difficult-to-treat asthma who are eligible for step up therapies, including new and emerging biologics

Activity Faculty

Bradley E. Chipps, MD, FAAP, FACAAI, FAAAAI, FCCP

Bradley E. Chipps, MD, FAAP, FACAAI, FAAAAI, FCCP

Past-President, American College of Allergy, Asthma & Immunology
Medical Director, Capital Allergy & Respiratory Disease Center
Sacramento, CA